Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fayza Hassanin
Observed names:
F. Hassanin,
Fayza Ahmed Mohamed Hassanin
Institution:
King Abdullah Medical City
Observed institution:
King Abdullah Medical City
ORCID:
0000-0002-7148-8678
Observed ORCID:
0000-0002-7148-8678
OpenAlex ID:
A5089798007
Optimizing the Communication with Cancer Patients During the COVID-19 Pandemic: Patient Perspectives
2020
·
Emad Tashkandi
, M BaAbdullah
, et al.
·
Patient Preference and Adherence
·
32
PDF
Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients
2020
·
Shereef Elsamany
, Gihan Hamdy Elsisi
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
8
Cost-Effectiveness of First-Line Cetuximab in Metastatic Colorectal Cancer in Saudi Arabia
2021
·
Shereef Elsamany
, Gihan Hamdy Elsisi
, et al.
·
Value in Health Regional Issues
·
4
PDF
Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey Study
2021
·
Shereef Elsamany
, Mohamed Elbaiomy
, et al.
·
JMIR Cancer
·
3
PDF
Knowledge and practices towards COVID-19 during its outbreak: A multinational cross-sectional study
2021
·
Ashitha Naser
, Eman Zmaily Dahmash
, et al.
·
Pharmacoepidemiology and Drug Safety
·
3
Suggested modifications in oncology/hematology inpatient service in Saudi Arabia during coronavirus disease-2019 (COVID-19) pandemic
2020
·
Shereef Elsamany
, Fayza Hassanin
, et al.
·
Avicenna Journal of Medicine
·
1
PDF
Pharmaco-economic assessment of subcutaneous compared to intravenous trastuzumab in HER2-positive breast cancer patients: A single institution experience.
2020
·
Shereef Ahmed Elsamany
, Mohamed Jafal
, et al.
·
Journal of Clinical Oncology
·
1
330P Randomized phase II study of neoadjuvant chemotherapy with denosumab compared to chemotherapy alone in hormonal receptor-positive, HER2-negative premenopausal breast cancer patients
2024
·
S.A. Elsamany Mohammed
, O. Elemam
, et al.
·
Annals of Oncology
Predictors of survival outcome of TAS102 combined with bevacizumab compared to TAS102 alone in Saudi patients with metastatic colorectal cancer beyond second line of systemic therapy.
2024
·
Shereef Ahmed Elsamany
, Hosam Alghanmi
, et al.
·
Journal of Clinical Oncology
PDF
244P Phase II randomized multicentre study comparing neoadjuvant chemoradiotherapy followed by consolidation chemotherapy to neoadjuvant chemoradiotherapy alone in non-metastatic rectal cancer patients
2024
·
S.A. Elsamany
, A. Aljubran
, et al.
·
Annals of Oncology
Impact of perioperative chemotherapy on survival outcome of advanced colorectal cancer patients treated with cytoreduction and hyperthermic intraperitoneal chemotherapy: A retrospective study.
2022
·
Shereef Ahmed Elsamany
, Saleh Alzahrani
, et al.
·
Journal of Clinical Oncology
899P Pharmacoeconomic assessment of subcutaneous retuximab formulation compared to intravenous retuximab in NHL and CLL patients: A single institution experience
2020
·
S. Ahmed Mohamed
, F. Hassanin
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
12
Citation count:
52
H-index:
3
I10-index:
1
Year
Topic
Type